Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
As a selective ghrelin receptor agonist, anamolin is approved in Japan for improving the health of cancer cachexia patients. By promoting appetite and gaining weight, it has a posi···【more】
Article source：Captain MedicineRelease date：2024-08-21Recommended：196
Through its unique pharmacological effects, Anamoreline is effective in helping cancer patients overcome weight loss and loss of appetite. Drugs have shown therapeutic potential in···【more】
Article source：Captain MedicineRelease date：2024-08-21Recommended：175
Anamorelin helps cancer patients with dyscrasia restore the body's energy supply by stimulating appetite and increasing growth hormone secretion. It is currently the only widel···【more】
Article source：Captain MedicineRelease date：2024-08-21Recommended：224
In 2021, Japan approved Anamorelin for the treatment of cachexia caused by various cancers such as non-small cell lung cancer. The drug has performed well in multiple clinical tria···【more】
Article source：Captain MedicineRelease date：2024-08-21Recommended：259
Anamorelin is a novel ghrelin receptor agonist specifically designed for the treatment of cancer cachexia. It provides vital support to patients with advanced cancer by increasing ···【more】
Article source：Captain MedicineRelease date：2024-08-21Recommended：329
Anamorelin is a selective oral medication that increases a patient's appetite and body weight primarily by activating ghrelin receptors. It is especially suitable for cancer pa···【more】
Article source：Captain MedicineRelease date：2024-08-21Recommended：241
Anamorelin is a ghrelin receptor agonist that is effective in improving appetite and muscle mass in patients with cancer cachexia. Drugs have shown good results in clinical trials,···【more】
Article source：Captain MedicineRelease date：2024-08-21Recommended：287
Anamorelin, the world's first oral drug specifically for the treatment of cancer cachexia, was launched by Ono Pharmaceutical of Japan in 2021. It helps patients regain their a···【more】
Article source：Captain MedicineRelease date：2024-08-21Recommended：211
Koselugois a small molecule drug inhibitor targeting the MEK signaling pathway, and its core utility is focused on specific neurofibromas and has demonstrated excellent therapeutic···【more】
Article source：Captain MedicineRelease date：2024-08-21Recommended：190
Koselugois a small molecule inhibitory drug targeting the MEK signaling pathway, and its core efficacy is reflected in its specific effect on specific neurofibromas, by blocking th···【more】
Article source：Captain MedicineRelease date：2024-08-21Recommended：208
Koselugo, as a small molecule blocker of the MEK signaling pathway, has a core effect on specific neurofibromatosis by inhibiting the growth and proliferation mechanism of tumor ce···【more】
Article source：Captain MedicineRelease date：2024-08-21Recommended：270
Koselugo is a small molecule inhibitor targeting the MEK signaling pathway, mainly used to treat specific types of neurofibromatosis, by blocking the growth and proliferation of tu···【more】
Article source：Captain MedicineRelease date：2024-08-21Recommended：241
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：672025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：3672024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended：612025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended：802025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended：752025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended：942025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended：902025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended：932025-27-11
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
